Dimensional Fund Advisors LP increased its position in UnitedHealth Group Inc. (NYSE:UNH) by 1.0% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,948,072 shares of the healthcare conglomerate’s stock after buying an additional 29,303 shares during the period. Dimensional Fund Advisors LP owned about 0.31% of UnitedHealth Group worth $416,242,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. MCF Advisors LLC boosted its stake in shares of UnitedHealth Group by 312.9% in the first quarter. MCF Advisors LLC now owns 958 shares of the healthcare conglomerate’s stock worth $123,000 after buying an additional 726 shares in the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of UnitedHealth Group by 31.4% in the second quarter. Parkside Financial Bank & Trust now owns 996 shares of the healthcare conglomerate’s stock worth $140,000 after buying an additional 238 shares in the last quarter. Feltz Wealth PLAN Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth $143,000. Benjamin F. Edwards & Company Inc. boosted its stake in shares of UnitedHealth Group by 91.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $153,000 after buying an additional 518 shares in the last quarter. Finally, Evanson Asset Management LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth $201,000. 85.78% of the stock is owned by institutional investors.
UnitedHealth Group Inc. (NYSE:UNH) opened at 140.51 on Friday. UnitedHealth Group Inc. has a 12-month low of $107.51 and a 12-month high of $144.48. The firm has a market cap of $133.82 billion, a P/E ratio of 21.99 and a beta of 0.57. The firm’s 50-day moving average price is $138.79 and its 200 day moving average price is $135.32.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 19th. The healthcare conglomerate reported $1.96 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.07. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The company had revenue of $46.50 billion for the quarter, compared to analysts’ expectations of $45.05 billion. Analysts forecast that UnitedHealth Group Inc. will post $7.92 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Friday, September 9th were issued a dividend of $0.625 per share. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a dividend yield of 1.78%. UnitedHealth Group’s dividend payout ratio is presently 39.12%.
Several equities analysts recently weighed in on UNH shares. Credit Suisse Group AG reissued a “buy” rating and set a $155.00 price objective (up previously from $148.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Zacks Investment Research cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research report on Monday, July 18th. Leerink Swann reissued a “buy” rating on shares of UnitedHealth Group in a research report on Monday, June 27th. FBR & Co reissued an “outperform” rating and set a $155.00 price objective (up previously from $145.00) on shares of UnitedHealth Group in a research report on Wednesday, July 20th. Finally, Royal Bank Of Canada boosted their price objective on UnitedHealth Group from $157.00 to $165.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 20th. One equities research analyst has rated the stock with a hold rating, twenty-four have assigned a buy rating and one has given a strong buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $154.96.
In other news, Director Richard T. Burke sold 40,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the transaction, the director now directly owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.65% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.